A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation

Blood

Volumn 104, Issue 8, 2004, Pages 2376-2384

  Daniel, Soizic ^a   Arvelo, Maria B ^a   Patel, Virendra I ^a   Longo, Christopher R ^a   Shrikhande, Gautam ^a   Shukri, Tala ^a   Mahiou, Jerome ^a   Sun, David W ^a   Mottley, Christina ^a   Grey, Shane T ^a   Ferran, Christiane ^a  

^a Department of Surgery and Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 8; COMPLEMENT; CYTOCHROME C; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BID; TUMOR NECROSIS FACTOR;

A20 GENE; ANIMAL CELL; APICAL MEMBRANE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 4944266955     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0635     Document Type: Article

References (64)

1. Opipari AJ, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem. 1990;265:14705-14708.
2. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem. 1996;271:18068-18073.
3. Ferran C, Stroka DM, Badrichani AZ, et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 1998;91:2249-2258.
4. Sarma V, Lin Z, Clark L, et al. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem. 1995;270:12343-12346.
5. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating NF-κB. J Biol Chem. 1992;267:24157-24160.
6. Laherty CD, Perkins ND, Dixit VM. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B. J Biol Chem. 1993;268:5032-5039.
7. Jäättela M, Mouritzen H, Elling F, Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol. 1996;156:1166-1173.
8. Beyaert R, Heyninck K, van Huffel S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochem Pharmacol. 2000;60:1143-1151.
9. Natoli G, Costanzo A, Guido F, et al. Nuclear factor κB-independent cytoprotective pathways originating at tumor-necrosis factor receptor-associated factor 2. J Biol Chem. 1998;273:31262-31272.
10. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today. 1997;18:483-486.
11. Yeong-Song H, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF-1/TRAF-2 and inhibits NF-κB activation. Proc Natl Acad Sci U S A. 1996;93:6721-6725.
12. Heynink K, Beyaert R. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6. FEBS Lett. 1999;442:147-150.
13. Heyninck K, De Valck D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J Cell Biol. 1999;145:1471-1482.
14. Van Huffel S, Delaei F, Heyninck K, De valck D, Beyaert R. Identification of a novel A20-binding inhibitor of nuclear factor-κB activation termed ABIN-2. J Biol Chem. 2001;276:30216-30223.
15. Zhang SQ, Kovalenko A, Cantarella G, Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity. 2000;12:301-311.
16. Klinkenberg M, Van Huffel S, Heyninck K, Beyaert R. Functional redundancy of the zinc fingers of A20 for inhibition of NF-κB activation and protein-protein interaction. FEBS Lett. 2001;498:93-97.
17. Opipari AJ, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from TNF cytotoxicity. J Biol Chem. 1992;267:12424-12427.
18. Janicke RU, Lee FH, Porter AG. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol Cell Biol. 1994;14:5661-5670.
19. Hess S, Gottfried E, Smola H, Grunwald U, Schuchmann M, Engelmann H. CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. Eur J Immunol. 1998;28:3594-3604.
20. Arvelo MB, Cooper JT, Longo C, et al. A20 protects mice from galactosmine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology. 2002;35:535-543.
21. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets. J Exp Med. 1999;190:1135-1145.
22. Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M, Pober JS. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interteukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest. 1997;77:257-267.
23. Varani J, Dame MK, Taylor CG, et al. Age-dependent injury in human umbilical vein endothelial cells: relationship to apoptosis and correlation with a lack of A20 expression. Lab Invest. 1995;73:851-858.
24. Wissing D, Mouritzen H, Jaattela M. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Rad Biol Med. 1998;25:57-65.
25. He KL, Ting AT. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor I complex in Jurkat T cells. Mol Cell Biol. 2002;22:6034-6045.
26. de Valck D, Jin DY, Heynink K, et al. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene. 1999;18:4182-4190.
27. Goodman DJ, von Albertini M, Willson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation. 1996;61:763-771.
28. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988;163:614-617.
29. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 1992;20:363-390.
30. Gross A, Yin XM, Wang K, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release while Bcl-xL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem. 1999;274:1156-1163.
31. Berard M, Mondiere P, Casamayor-Palleja M, Hennino A, Bella C, Defrance T. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J Immunol. 1999;163:4655-4662.
32. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit J Cancer. 1972;26:239-257.
33. Wilson MR. Apoptotic signal transduction: emerging pathways. Biochem Cell Biol. 1998;76:573-582.
34. Matter-Reissmann UB, Forte P, Schneider MK, Filgueira L, Groscurth P, Seebach JD. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression. Xenotransplantation. 2002;9:325-337.
35. Chinnayian AM, O'Rourke K, Tewari M, Dixit V. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
36. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299-308.
37. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1 and TNF-receptor-induced cell death. Cell. 1996;85:803-815.
38. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell. 1996;85:817-827.
39. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Ann Rev Physiol. 1998;60:619-642.
40. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.
41. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491-501.
42. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481-490.
43. Hu Y, Benedict MA, Ding L, Nunez G. Role of cytochrome c and dATP/ATP hydrolysis in apaf-1-mediated caspase- 9 activation and apoptosis. EMBO J. 1999;18:3586-3595.
44. Li H, Bergeron L, Cryns V, et al. Activation of caspase 2 in apoptosis. J Biol Chem. 1997;272:21010-21017.
45. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 1999;144:281-292.
46. Yen WC, Pompa JL, McCurrach ME, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998;279:1954-1958.
47. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature. 1997;385:86-89.
48. Ahmad M, Srinivasula SM, Wang L, et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 1997;57:615-619.
49. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 stress-induced apoptosis before mitochondrial permeabilization. Science. 2002;297:1352-1354.
50. Lademann U, Kallunki T, Jaattela M. A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins. Cell Death Differ. 2001;8:265-272.
51. Krammer PH. CD95's deadly mission in the immune system. Nature. 2000;407:789-795.
52. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675-1687.
53. Li JH, Kluger MS, Madge LA, Zheng L, Bothwell AL, Pober JS. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol. 2002;161:1485-1495.
54. Van den Broek MF, Kagi D, Hengartner H. Effector pathways of natural killer cells. Curr Top Microbiol Immunol. 1998;230:123-131.
55. Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunol Today. 2000;254:254-256.
56. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nature Rev Immunol. 2002;2:735-747.
57. Zheng L, Ben LH, Pober JS, Bothwell ALM. Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2. J Immunol. 2002;169:6850-6855.
58. Atkinson EA, Barry M, Darmon AJ, et al. Cytotoxic T lymphocyte-assisted suicide. J Biol Chem. 1998;273:21261-21266.
59. Barry M, Heiben JA, Pinkoski MJ, et al. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol. 2000;20:3781-3794.
60. Sarin A, Haddad EK, Henkart PA. Caspase dependence of target cell damage induced by cytotoxic lymphocytes. J Immunol. 1998;161:2810-2816.
61. Henkart PA, Williams MS, Zacharchuk CM, Sarin A. Do CTL kill target cells by inducing apoptosis? Semin Immunol. 1997;9:135-144.
62. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med. 1995;181:21-31.
63. Papadimitriou JC, Drachenberg CB, Shin ML, Trump BF. Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Arch. 1994;424:677-685.
64. Heyninck K, Denecker G, de Valck D, Fiers W, Beyaert R. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. Anticancer Res. 1999;19:2863-2868.